Form 4 for MBRX Moleculin Biotech, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001437749-22-027949 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-21 | MBRX | KLEMP WALTER V | CEO, Pres, Dir | P - Purchase | $1.15 | +22.5K | 364.9K | +7% | +$25.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | P | A | 22,500 | $1.15 | 364,890 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.12 to $1.17. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |